Other factors were explored to predict the clinical response to anti-IL-5 mAb (N-ERD, previous surgery, sex, smoking habit, comorbid conditions: emphysema, bronchiectasis, sleep apnea, asthma, gastroesophageal reflux, diabetes, hypercholesterolemia and/or hypertension). Here, IL5 is linked to Sleep apnea.